Jpmorgan Chase & CO Stereotaxis, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 39,106 shares of STXS stock, worth $83,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,106
Previous 134,822
70.99%
Holding current value
$83,295
Previous $307,000
77.85%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STXS
# of Institutions
97Shares Held
40.9MCall Options Held
70.8KPut Options Held
41.9K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$29.1 Million7.27% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.38MShares$9.33 Million4.91% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$7.53 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.08 Million5.31% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $159M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...